气球心房隔膜术:一种武器,以挑战心脏手术后的右心力衰竭
Weijun Yang1, Zhean Shen2, Manxuan Zhu3
1Department of Cardiovascular Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, P.R. China.
Journal of cardiothoracic surgery
|July 2, 2024
概括
气球心房隔膜术提供了一种新的方法来治疗心脏手术后的右心力衰竭. 这种方法有望改善患者的治疗结果,并可能减少对机械循环支持的需求.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 右心力衰竭是心脏手术后的常见和严重并发症.
- 现有的治疗方法,如医疗管理和静脉动脉外体膜氧化,对一些患者有局限性.
- 一部分患者可能需要先进的干预措施,例如长期的机械循环支持或心脏移植.
研究的目的:
- 评估气球心房隔膜术作为心脏手术后右心力衰竭的新型治疗方法的疗效.
- 探索气球心房间隔膜术的潜力,以预防或减少对机械循环支持的依赖.
主要方法:
- 一系列病例报告了心脏手术后右心力衰竭患者气球心房隔膜术的应用.
- 专注于治疗患者观察到的临床结果和益处.
主要成果:
- 在本系列中,所有接受气球心房隔膜术治疗的患者都经历了积极的益处.
- 该程序在研究队列中的右心力衰竭管理方面表现出有效性.
结论:
- 气球心房间间隔膜术为心脏手术后右心力衰竭提供了一个有前途的新疗法选择.
- 这种技术可以作为机械循环支持的替代方案,改善患者的康复和预后.
- 根据观察到的益处,建议由合格的心脏外科医生进行临床实施.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


